Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyâ
2026-03-16CRNX144Richard Scott Struthers plan to sell securities of Crinetics Pharmaceuticals, Inc. under Form 144MEDIUM
Richard Scott Struthers filed Form 144 to notify SEC of plan to sell 45013 units of Crinetics Pharmaceuticals, Inc. securities around 2026-03-16, with aggregate market value of $1,687,537.00. The total outstanding units is 104705300.0. The amount planned to be sold represents 0.04% of total outstanding units; ...
Mid CapBiotechnology
2026-03-16CRNX144Jeff Knight plan to sell securities of Crinetics Pharmaceuticals Inc under Form 144MEDIUM
Jeff Knight filed Form 144 to notify SEC of plan to sell 25113 units of Crinetics Pharmaceuticals Inc securities around 2026-03-16, with aggregate market value of $941,486.00. The total outstanding units is 104705300.0. The amount planned to be sold represents 0.02% of total outstanding units; ...
Mid CapBiotechnology
2026-03-16AVTX144MITTIE DOYLE plan to sell securities of AVALO THERAPEUTICS, INC. under Form 144MEDIUM
MITTIE DOYLE filed Form 144 to notify SEC of plan to sell 29529 units of AVALO THERAPEUTICS, INC. securities around 2026-03-16, with aggregate market value of $466,558.20. The total outstanding units is 18133968.0. The amount planned to be sold represents 0.16% of total outstanding units; ...
Micro CapBiotechnology